Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oftac in Active Non-Infectious Anterior Uveitis
NCT07869953Phase 2Completed
- Sponsor
- BioNanoSim
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Oftac, sponsored by BioNanoSim. Started Mar 2024; status: completed.
02
Drugs
Oftac
Beyond the preview
Go deeper on NCT07869953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869953.